TechCrunch | 09.18.18

Announcing Our Investment In Ro

By Josh Costine

FirstMark is proud to announce our Series A investment in Ro (formerly known as Roman). Founded by Zach Reitano, Saman Rahmanian, and Rob Schutz, Ro is tearing down the traditional healthcare walls and bringing providers and patients together in one place. Ro is making it easier for millions of people to get personalized treatment, get healthy and get back to living the life they want to live. TechCrunch covered the news (below).

Roman is a rocket ship, and I’m not talking about how it sells Viagra and Cialis. Less than a year after launching its cloud pharmacy for erectile dysfunction with $3 million in funding and a five-person team, Roman has grown to seventy team members and a revenue run-rate in the 10s of millions — up 720 percent since January. It’s sparked over a million patient-physician visits, phone calls, and text conversations through its telemedicine portal for getting diagnoses and prescriptions.

And now Roman is ready to expand beyond men, so it’s dropping the ‘Man.

Today, the newly renamed ‘Ro’ unveiled its next product, Zero, a $129 ‘quit smoking’ kit. It contains a month’s worth of prescription cessation medication bupropion and nicotine gum, plus an app for tracking progress and learning how to stay motivated through hunger, nausea, and cravings. Pre-orders open today.

Read the full article on TechCrunch